iFAST Diagnostics Ltd, has been awarded The Institute of Biomedical Science Award for Best Use of Research.

The IBMS Best Use of Research Award was awarded to iFAST Diagnostics for research work carried out between 1 January 2025 and 31 December 2025, providing clinical validation of claims to consistently give accurate, rapid Antimicrobial Susceptibility Test (AST) results, from a Gram-negative positive blood culture, in under 3 hours.

Known to be one of the most prestigious accolades for the biomedical science profession, The IBMS Awards celebrate and champion outstanding biomedical science practice.

With over 21,000 members in 74 countries, the Institute of Biomedical Science (IBMS) is the leading professional body for scientists, support staff and students in the field of biomedical science.

The IBMS Judges said: “The iFast Diagnostics Ltd project stood out overall for its current clinical importance in addressing the increasing problems of AMR. The submission demonstrated rigorous, ISO-validated research, cutting-edge technology, with transformative clinical impact by delivering rapid AST results under three hours.”

Dr Toby King, CEO, iFAST Diagnostics said: “We are absolutely delighted to receive the IBMS Award for Best Use of Research. It’s a fantastic reward for everyone who has worked so hard to bring our ultra-rapid, low cost, antimicrobial susceptibility testing technology to market. Thank you to everyone – the individuals, teams and organisations who contributed and supported this project with outstanding work.”

To learn more about the iFAST clinical trial, click here.

The IBMS Awards cover 12 categories celebrating excellence in biomedical science.

In addition to being recognised for Best Use of Research, iFAST Diagnostics was short listed for the IBMS Award for Best Use of Innovation or Technology.

Joanna Andrew, IBMS Past President said: “The IBMS Awards not only celebrate the outstanding achievements of our members, but they also inspire the next generation of biomedical scientists. Each award represents a commitment to excellent, innovation and the advancement of our profession. By recognising these contributions, we strengthen our community and continue to elevate the essential role of biomedical science in healthcare.”

The full list of IBMS Award Winners 2026 are available here: